T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited - life sciences in Bangakore, Karnataka, India. FY 2026 financials and compliance.
CIN U73100KA2021PTC149735 Incorporated 20 July 2021 ROC Bangalore HQ Bangakore, Karnataka, India
Active Private Limited Company life sciences
Data last updated
Revenue · FY 2023
₹30,060
▼ 60.00% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.05 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
5 yrs
Est. 2021
Last financials
Mar 2023
Balance sheet date

About T-3 Molecular Genetics (T-3 Mgen) Private Limited

Data last updated: 27 February 2026

T-3 Molecular Genetics (T-3 Mgen) Private Limited is a private limited company based in Bangakore, Karnataka, India, recognised as a startup by DPIIT. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 20 July 2021, the company has been in operation for over 5 years.

Registered with ROC Bangalore under CIN U73100KA2021PTC149735.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.05 Lakh. It is led by directors including Narendra Dnyanoba Dhele and Shankarrao Baburao Patil.

Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: Bangalore Bioinnovation Centr (Bbc) Electronic City Phase – 1 Kar – 560100, Bangakore, Karnataka, India – 560100.

As per the financials filed for FY 2023, the company reported a revenue of ₹30,060, a decline of 60% compared to the previous year.

The company is associated with 1 brand - T3 Mgen.

For more details, the company can be reached via its website t3mgen.com.

Company Details of T-3 Molecular Genetics (T-3 Mgen) Private Limited
CIN U73100KA2021PTC149735
Registration Number 149735
Incorporation Date 20 July 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Bangalore Bioinnovation Centr (Bbc) Electronic City Phase – 1 Kar – 560100, Bangakore, Karnataka, India – 560100
  • Industry
    Life Sciences, Biotechnology
Company report
T-3 Molecular Genetics (T-3 Mgen) Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full T-3 Molecular Genetics (T-3 Mgen) Private Limited report

Financials, compliance, directors, charges, ownership and filings for T-3 Molecular Genetics (T-3 Mgen) Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited operates one associated brand: T3 MGen. These brands represent T-3 Molecular Genetics (T-3 Mgen) Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Develops proprietary technologies for immune therapeutics against diseases using AI and multidisciplinary research. t3mgen.com

Competitors & Alternatives of T-3 Molecular Genetics (T-3 Mgen) Private Limited

Brands and companies operating in the same space as T-3 Molecular Genetics (T-3 Mgen) Private Limited include Moderna, Juno Therapeutics, Adaptive Biotechnologies and 4 more.

Competitor Description Location Founded
Moderna Moderna mRNA-based therapeutics for diseases including cancer and infections are developed. Cambridge, United States, United States 2010
Juno Therapeutics Juno Therapeutics CAR T-cell and T-cell receptor immunotherapies for cancer are developed. Seattle, United States, United States 2013
Adaptive Biotechnologies Adaptive Biotechnologies Clinical diagnostics and drug discovery for immune diseases are provided. Seattle, United States, United States 2009
Escient Pharmaceuticals Escient Pharmaceuticals Small molecule therapeutics for inflammatory diseases are developed. San Diego, United States, United States 2017
Poseida Therapeutics Poseida Therapeutics Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies San Diego, United States, United States 2015
Aclaris Therapeutics Aclaris Therapeutics Novel dermatologic therapies are developed for skin conditions. Malvern, United States, United States 2012
Chimerix Chimerix Antiviral oral therapeutics are developed for infectious diseases and cancers. Durham, United Kingdom, United Kingdom 2002

Business Activity of T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited is audited by MORDE & RETWADE for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
MORDE & RETWADE Locked Locked Locked
Premium access

Complete auditor history for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Narendra Dnyanoba Dhele Director 20 Jul 2021 5 Years 0 Months Current
Shankarrao Baburao Patil Director 20 Jul 2021 5 Years 0 Months Current
Nameirakpam Bunindro Singh Director 20 Jul 2021 5 Years 0 Months Current

Financials of T-3 Molecular Genetics (T-3 Mgen) Private Limited FY 2023 filings available

T-3 Molecular Genetics (T-3 Mgen) Private Limited reported revenue of ₹30,060 (down 60.00% YoY) for FY 2023.

Revenue · FY 2023
₹30,060 ▼ 60.00%
Premium access

Ten-year financial statements for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of T-3 Molecular Genetics (T-3 Mgen) Private Limited

Premium access

Shareholding and ownership data for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited has a workforce of 0 employees as of Apr 04, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of T-3 Molecular Genetics (T-3 Mgen) Private Limited

Premium access

GST registrations and filing compliance for T-3 Molecular Genetics (T-3 Mgen) Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by T-3 Molecular Genetics (T-3 Mgen) Private Limited

Premium access

MSME payment history for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of T-3 Molecular Genetics (T-3 Mgen) Private Limited

Premium access

Corporate group structure for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of T-3 Molecular Genetics (T-3 Mgen) Private Limited

Premium access

MCA filings and documents for T-3 Molecular Genetics (T-3 Mgen) Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on T-3 Molecular Genetics (T-3 Mgen) Private Limited

Activity
30 Sep 2023
T-3 Molecular Genetics (T-3 Mgen) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Activity
31 Mar 2023
T-3 Molecular Genetics (T-3 Mgen) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Directors
20 Jul 2021
Narendra Dnyanoba Dhele was appointed as a Director on 20 Jul 2021 & has been associated with this company since 5 years 26 days.
Directors
20 Jul 2021
Shankarrao Baburao Patil was appointed as a Director on 20 Jul 2021 & has been associated with this company since 5 years 26 days.
Directors
20 Jul 2021
Nameirakpam Bunindro Singh was appointed as a Director on 20 Jul 2021 & has been associated with this company since 5 years 26 days.
Activity
20 Jul 2021
T-3 Molecular Genetics (T-3 Mgen) Private Limited was registered on 20 Jul 2021 with Roc Bangalore & aged 5 years 26 days as per MCA records.

Frequently Asked Questions about T-3 Molecular Genetics (T-3 Mgen) Private Limited

T-3 Molecular Genetics (T-3 Mgen) Private Limited is an active private limited company in the life sciences sector based in Bangakore, Karnataka, India. It was incorporated on 20 July 2021 (5+ years old) and is registered under CIN U73100KA2021PTC149735.

T-3 Molecular Genetics (T-3 Mgen) Private Limited reported revenue of ₹30,060 for FY 2023 (down 60.00% YoY).

The current directors of T-3 Molecular Genetics (T-3 Mgen) Private Limited are:

The primary industry of T-3 Molecular Genetics (T-3 Mgen) Private Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Yes, T-3 Molecular Genetics (T-3 Mgen) Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

T-3 Molecular Genetics (T-3 Mgen) Private Limited can be reached at the registered office: Bangalore Bioinnovation Centr Bbc Electronic City Phase – 1 Kar – 560100, Bangakore, Karnataka, India – 560100, or through the website t3mgen.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available